Falkai P - Search Results

1

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU. Howes OD, et al. Among authors: falkai p. Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6. Am J Psychiatry. 2017. PMID: 27919182 Free PMC article. Review.

2

Developmental abnormalities of the hippocampus in first-episode schizophrenia.

Smith GN, Lang DJ, Kopala LC, Lapointe JS, Falkai P, Honer WG. Smith GN, et al. Among authors: falkai p. Biol Psychiatry. 2003 Apr 1;53(7):555-61. doi: 10.1016/s0006-3223(02)01977-7. Biol Psychiatry. 2003. PMID: 12679232

3

Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.

Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ, Falkai P, Phillips AG, Honer WG. Sawada K, et al. Among authors: falkai p. Arch Gen Psychiatry. 2005 Mar;62(3):263-72. doi: 10.1001/archpsyc.62.3.263. Arch Gen Psychiatry. 2005. PMID: 15753239

4

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ; WFSBP Task Force on Treatment Guidelines for Schizophrenia. Falkai P, et al. World J Biol Psychiatry. 2005;6(3):132-91. doi: 10.1080/15622970510030090. World J Biol Psychiatry. 2005. PMID: 16173147 Review.

5

Clozapine alone versus clozapine and risperidone with refractory schizophrenia.

Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R; Clozapine and Risperidone Enhancement (CARE) Study Group. Honer WG, et al. Among authors: falkai p. N Engl J Med. 2006 Feb 2;354(5):472-82. doi: 10.1056/NEJMoa053222. N Engl J Med. 2006. PMID: 16452559 Free article. Clinical Trial.

6

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.

Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ; WFSBP Task Force on Treatment Guidelines for Schizophrenia. Falkai P, et al. World J Biol Psychiatry. 2006;7(1):5-40. doi: 10.1080/15622970500483177. World J Biol Psychiatry. 2006. PMID: 16509050

7

Reduction of the internal capsule in families affected with schizophrenia.

Wobrock T, Kamer T, Roy A, Vogeley K, Schneider-Axmann T, Wagner M, Maier W, Rietschel M, Schulze TG, Scherk H, Schild HH, Block W, Träber F, Tepest R, Honer WG, Falkai P. Wobrock T, et al. Among authors: falkai p. Biol Psychiatry. 2008 Jan 1;63(1):65-71. doi: 10.1016/j.biopsych.2007.02.026. Epub 2007 Jun 15. Biol Psychiatry. 2008. PMID: 17574215

8

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia. Gaebel W, et al. Among authors: falkai p. J Clin Psychiatry. 2007 Nov;68(11):1763-74. doi: 10.4088/jcp.v68n1116. J Clin Psychiatry. 2007. PMID: 18052570 Clinical Trial.

9

Automated gray level index measurements reveal only minor cytoarchitectonic changes of Brodmann area 9 in schizophrenia.

Tepest R, Vogeley K, Viebahn B, Schneider-Axmann T, Honer WG, Falkai P. Tepest R, et al. Among authors: falkai p. Psychiatry Res. 2008 Jul 15;163(2):183-92. doi: 10.1016/j.pscychresns.2007.09.002. Epub 2008 May 27. Psychiatry Res. 2008. PMID: 18508245

., Schneider-Axmann, T., Hutte, H., Zilles, K., Honer, W.G., Falkai, P., 2003. Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia, Schizophrenia Research 62, 133-140]. ...

., Schneider-Axmann, T., Hutte, H., Zilles, K., Honer, W.G., Falkai, P., 2003. Automated image analysis of disturbed cytoarchi …

10

Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.

Stober G, Ben-Shachar D, Cardon M, Falkai P, Fonteh AN, Gawlik M, Glenthoj BY, Grunblatt E, Jablensky A, Kim YK, Kornhuber J, McNeil TF, Muller N, Oranje B, Saito T, Saoud M, Schmitt A, Schwartz M, Thome J, Uzbekov M, Durany N, Riederer P. Stober G, et al. Among authors: falkai p. World J Biol Psychiatry. 2009;10(2):127-55. doi: 10.1080/15622970902898980. World J Biol Psychiatry. 2009. PMID: 19396704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

877 results

Search Page